Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Neprilysin is a mediator of alternative renin-angiotensin-system activation in the murine and human kidney

[img]
Preview
PDF (Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
853kB
[img]
Preview
PDF (Supplementary Information) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
2MB

Item Type:Article
Title:Neprilysin is a mediator of alternative renin-angiotensin-system activation in the murine and human kidney
Creators Name:Domenig, O. and Manzel, A. and Grobe, N. and Königshausen, E. and Kaltenecker, C.C. and Kovarik, J.J. and Stegbauer, J. and Gurley, S.B. and van Oyen, D. and Antlanger, M. and Bader, M. and Motta-Santos, D. and Santos, R.A. and Elased, K.M. and Säemann, M.D. and Linker, R.A. and Poglitsch, M.
Abstract:Cardiovascular and renal pathologies are frequently associated with an activated renin-angiotensin-system (RAS) and increased levels of its main effector and vasoconstrictor hormone angiotensin II (Ang II). Angiotensin-converting-enzyme-2 (ACE2) has been described as a crucial enzymatic player in shifting the RAS towards its so-called alternative vasodilative and reno-protective axis by enzymatically converting Ang II to angiotensin-(1-7) (Ang-(1-7)). Yet, the relative contribution of ACE2 to Ang-(1-7) formation in vivo has not been elucidated. Mass spectrometry based quantification of angiotensin metabolites in the kidney and plasma of ACE2 KO mice surprisingly revealed an increase in Ang-(1-7), suggesting additional pathways to be responsible for alternative RAS activation in vivo. Following assessment of angiotensin metabolism in kidney homogenates, we identified neprilysin (NEP) to be a major source of renal Ang-(1-7) in mice and humans. These findings were supported by MALDI imaging, showing NEP mediated Ang-(1-7) formation in whole kidney cryo-sections in mice. Finally, pharmacologic inhibition of NEP resulted in strongly decreased Ang-(1-7) levels in murine kidneys. This unexpected new role of NEP may have implications for the combination therapy with NEP-inhibitors and angiotensin-receptor-blockade, which has been shown being a promising therapeutic approach for heart failure therapy.
Keywords:Aminobutyrates, Angiotensin I, Angiotensin II, Angiotensin II, Biomarkers, Biopsy, Biphenyl Compounds, Gene Expression, Immunohistochemistry, Kidney, Kidney Cortex, Neprilysin, Peptide Fragments, Peptidyl-Dipeptidase A, Renin, Renin-Angiotensin System, Animals, Mice
Source:Scientific Reports
ISSN:2045-2322
Publisher:Nature Publishing Group
Volume:6
Page Range:33678
Date:21 September 2016
Official Publication:https://doi.org/10.1038/srep33678
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library